This inventor holds 3 USPTO granted patents. Top assignees: Rorer Pharmaceutical Corporation, Usv Pharmaceutical Corporation. Active years: 1988-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bronx, NY (US) (1988 - 1989)
- Horsham, PA (US) (1991)
Company Filing History:

Years Active: 1988-1991
Title: Abdur R Purkaystha: Innovator in Pharmaceutical Formulations
Introduction
Abdur R Purkaystha is a notable inventor based in Bronx, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 3 patents to his name, his work has had a meaningful impact on the industry.
Latest Patents
Among his latest patents is the formulation of calcitonin suppositories. This invention discloses rectal and vaginal suppository formulations that comprise calcitonin and caprylic acid monoglyceride in a pharmaceutically acceptable vehicle. Another significant patent involves the stabilization of multivitamin and trace element formulations. This patent reveals aqueous formulations stabilized by a water-soluble organic acid that contains carbon-to-carbon unsaturation, along with water-soluble salts selected from maleic acid, fumaric acid, maleamic acid, and acrylic acid.
Career Highlights
Abdur R Purkaystha has worked with prominent companies in the pharmaceutical sector, including Rorer Pharmaceutical Corporation and Usv Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include James Cahill and Morris Kesselman. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Abdur R Purkaystha's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of complex formulations that can enhance therapeutic efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile